KRYS Sale Disclosure
Rossi Dino A · SEC Form 4 · Filed Aug 14, 2026
Sale
Calculated transaction value
$2.45M
Rossi Dino A Director
KRYS
Krystal Biotech
KRYS
Transaction date
Aug 14, 2026
Public filing date
Aug 14, 2026
Filing lag
Filed same day
KRYS daily price context
Close on/before transaction
$332.27
Aug 14, 2026
Close before public filing
$328.34
Aug 13, 2026
Return since public filing
+2.54%
Through Sep 15, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 7,428 shares @ $329.6
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001209059-26-000006
Filing cohort
Transactions in this filing
Showing 9 of 9
Trades
9
Issuers
1
Estimated value
$8.23M
Buys / sales
0 / 8
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Krystal Biotech, Inc. KRYS | Gift | Aug 14, 2026 | $0 |
| Krystal Biotech, Inc. KRYS | Sale | Aug 14, 2026 | $746.94K |
| Krystal Biotech, Inc. KRYS | Sale | Aug 14, 2026 | $13.33K |
| Krystal Biotech, Inc. KRYS | Sale | Aug 14, 2026 | $1.03M |
| Krystal Biotech, Inc. KRYS | Sale | Aug 14, 2026 | $1.62M |
| Krystal Biotech, Inc. KRYS | Sale | Aug 14, 2026 | $1.71M |
| Krystal Biotech, Inc. KRYS | Sale | Aug 14, 2026 | $554.21K |
| Krystal Biotech, Inc. KRYS Current | Sale | Aug 14, 2026 | $2.45M |
| Krystal Biotech, Inc. KRYS | Sale | Aug 14, 2026 | $111.03K |